Webinar
Strategic considerations following the Inflation Reduction Act implementation
calendar

January 25, 2024

Calendar
clock

3:00pm - 3:30pm

(GMT+08:00)

Register

View all IQVIA events

Inflation Reduction Act (IRA) implementation is leading to transformational changes in the life sciences industry. Medicare recently selected the first 10 products that will be subject to price negotiations, which will show implications throughout the products' lifecycle. The need for more evidence at launch to accelerate adoption for the right indications will be a key driver for strategic considerations in the US market and beyond.

Webinar attendees will:

  • Gain an understanding of IRA implications, including up to date conversations on the latest trends
  • Explore strategic considerations including the role of RWE early in the lifecycle to accelerate launch and adoption
Contact Us